Literature DB >> 1709023

Structural stability of paired helical filaments requires microtubule-binding domains of tau: a model for self-association.

H Ksiezak-Reding1, S H Yen.   

Abstract

Highly purified and SDS-soluble paired helical filaments (PHFs) were immunogold labeled and immunoblotted with antibodies to tau: Tau 14 (N-terminal half), AH-1 (microtubule-binding domain), and Tau 46 (C-terminal end). The main component of PHFs was modified tau of 68, 64, and 60 kd, also called A68 or PHF-tau. Trypsin digestion reduced the maximum width of PHFs by 10%-20%, increased aggregation of filaments, and abolished the binding of Tau 14, but had no effect on the binding of AH-1. The smallest tau-reactive tryptic fragments were 13 and 7-8 kd, positive with AH-1, and negative with Tau 46. Our results and the model of Crowther and Wischik suggest that by self-association and anti-parallel arrangement of the microtubule-binding domains, PHF-tau forms the backbone of PHFs.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1709023     DOI: 10.1016/0896-6273(91)90169-z

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  32 in total

1.  Tau dephosphorylation at tau-1 site correlates with its association to cell membrane.

Authors:  M Arrasate; M Pérez; J Avila
Journal:  Neurochem Res       Date:  2000-01       Impact factor: 3.996

2.  Immunocytochemistry of neurofibrillary tangles with antibodies to subregions of tau protein: identification of hidden and cleaved tau epitopes and a new phosphorylation site.

Authors:  D W Dickson; H Ksiezak-Reding; W K Liu; P Davies; A Crowe; S H Yen
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

3.  Role of glycosaminoglycans in determining the helicity of paired helical filaments.

Authors:  M Arrasate; M Pérez; J M Valpuesta; J Avila
Journal:  Am J Pathol       Date:  1997-10       Impact factor: 4.307

4.  Phosphorylated tau immunoreactivity of granulovacuolar bodies (GVB) of Alzheimer's disease: localization of two amino terminal tau epitopes in GVB.

Authors:  D W Dickson; W K Liu; Y Kress; J Ku; O DeJesus; S H Yen
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

5.  A protein kinase, PKN, accumulates in Alzheimer neurofibrillary tangles and associated endoplasmic reticulum-derived vesicles and phosphorylates tau protein.

Authors:  T Kawamata; T Taniguchi; H Mukai; M Kitagawa; T Hashimoto; K Maeda; Y Ono; C Tanaka
Journal:  J Neurosci       Date:  1998-09-15       Impact factor: 6.167

6.  The fuzzy coat of pathological human Tau fibrils is a two-layered polyelectrolyte brush.

Authors:  Susanne Wegmann; Izhar D Medalsy; Eckhard Mandelkow; Daniel J Müller
Journal:  Proc Natl Acad Sci U S A       Date:  2012-12-26       Impact factor: 11.205

7.  Twisted tubulofilaments of inclusion body myositis muscle resemble paired helical filaments of Alzheimer brain and contain hyperphosphorylated tau.

Authors:  V Askanas; W K Engel; M Bilak; R B Alvarez; D J Selkoe
Journal:  Am J Pathol       Date:  1994-01       Impact factor: 4.307

8.  Tau phosphorylation at Alzheimer's disease-related Ser356 contributes to tau stabilization when PAR-1/MARK activity is elevated.

Authors:  Kanae Ando; Mikiko Oka; Yosuke Ohtake; Motoki Hayashishita; Sawako Shimizu; Shin-Ichi Hisanaga; Koichi M Iijima
Journal:  Biochem Biophys Res Commun       Date:  2016-08-09       Impact factor: 3.575

9.  Ganglioglioma with neurofibrillary tangles (NFTs): neoplastic NFTs share antigenic determinants with NFTs of Alzheimer's disease.

Authors:  D Soffer; F Umansky; J E Goldman
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

10.  Ferritin is associated with the aberrant tau filaments present in progressive supranuclear palsy.

Authors:  M Pérez; J M Valpuesta; E M de Garcini; C Quintana; M Arrasate; J L López Carrascosa; A Rábano; J García de Yébenes; J Avila
Journal:  Am J Pathol       Date:  1998-06       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.